Lubiprostone Capsule, Gelatin Coated
Product Images NDC 0254-3029

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 0254-3029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lubiprostone 01)

FDA Label Image

Principal Display Panel (8 mcg Capsule Bottle Label)

This is a description of a medication called TTTTOE G TN Nocozss-3028.02 capsules produced by Par Pharmaceutical. The capsules come in a package of 60 capsules and should be swallowed whole and kept in a tightly closed, light-resistant container. The active ingredient is made in Japan and encapsulated in the United States. Each capsule contains B meg of lubiprostone. The package insert should be consulted for complete prescribing information. The text also provides a warning to keep the medication out of reach of children.*

FDA Label Image

Principal Display Panel (24 mcg Capsule Bottle Label)

This is a prescription drug with the name Lubiprostone. Each soft gel capsule contains 28 mg of biprostone which should be swallowed whole and not chewed or broken apart. The drug comes in a tightly closed, light-resistant container containing 60 capsules, with 24 mcg Fe3 Z3E3. The complete prescribing information can be found in the package insert. The medication should be kept out of reach of children. It is manufactured by Par Pharmaceutical in Chestnut Ridge, NY, using an active ingredient made in Japan and encapsulated in the United States.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.